—

Novonesis (Novozymes) A/S (NSIS-B.CO) — the peer cohort

As of 2026-10-30 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Novonesis (Novozymes) A/S ranks 7 of 7 in its cohort on the Closelooknet composite (49/100) — the cohort is led by Sociedad Quimica y Minera de Chile SA ADR B at 60/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
NSIS-B.CO Novonesis (Novozymes) A/S 49 83 49 16 ok 4%
SQM Sociedad Quimica y Minera de Chile SA ADR B 60 16 69 76 warn 43.8%
SSL Sasol Ltd 59 89 49 91 ok 5.3%
ALPEKA.MX ALPEK S.A.B. de C.V 52 88 23 80 ok 6.6%
LIN Linde plc Ordinary Shares 51 60 62 28 bull 6.2%
CLN.SW Clariant AG 50 84 31 74 info 8.1%
GIVN.SW Givaudan SA 50 89 64 36 bull 1%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-30

Quick answers

Who are Novonesis (Novozymes) A/S's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Sociedad Quimica y Minera de Chile SA ADR B (SQM), Sasol Ltd (SSL), ALPEK S.A.B. de C.V (ALPEKA.MX), Linde plc Ordinary Shares (LIN), Clariant AG (CLN.SW), Givaudan SA (GIVN.SW), as of 2026-10-30.

How does NSIS-B.CO score against its peers?

Novonesis (Novozymes) A/S's composite reads 49/100, ranking 7 of 7 in its cohort as of 2026-10-30; the cohort's highest composite is Sociedad Quimica y Minera de Chile SA ADR B at 60/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Specialty Chemicals. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.